D. Geft, Los Angeles, CA, United States of America
Cedars-Sinai Heart InstitutePoster Author Of 4 e-Posters
726 - Does the Type of Mechanical Circulatory Support as a Bridge to Heart Transplant Affect Outcome after Transplant?
Presentation Number
726
Session Name
PO-1-MCS - Poster Session 1: Mechanical Circulatory Support
Date
Wed, Apr 11, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- F. Arabia, Los Angeles, CA, United States of America
- H. Barone, Los Angeles, CA, United States of America
- R. Cole, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- G. Esmailian, Los Angeles, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Moriguchi, Los Angeles, CA, United States of America
- E. Passano, Los Angeles, CA, United States of America
- M. Rafiei, Los Angeles, CA, United States of America
876 - Does Commuting Time to the Transplant Center Affect Compliance with Visits and Outcome after HTx in a big Metropolitan Area?
Presentation Number
876
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- T. Kao, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Patel, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
1131 - Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
Presentation Number
1131
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- N. Lam, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- D. Luthringer, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1138 - In Sensitized Pre-Transplant Patients, Does IVIG after Heart Transplant Have any Benefit?
Presentation Number
1138
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- B. Kearney, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America